FRIDAY, May 9, 2025 (HealthDay News) -- mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

"Supply and demand" constraints limit the body's ability to produce the various proteins needed for critical life functions, ...

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.